Becton, Dickinson and Company (BDX) Traded Down on Weak Earnings

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter. The fund underperformed its benchmark, the MSCI World Index (net), in the second quarter. A copy of the letter can be downloaded here. The largest performance contributors were industrials and financials, at the sector level, while health care and energy detracted. In addition, you can check the top 5 holdings of the fund to know its best picks in 2025.

In its second quarter 2025 investor letter, Oakmark Global Fund highlighted stocks such as Becton, Becton, Dickinson and Company (NYSE:BDX). Becton, Dickinson and Company (NYSE:BDX) is a medical device company that develops and manufactures medical supplies, devices, laboratory equipment, and diagnostic products. The one-month return of Becton, Dickinson and Company (NYSE:BDX) was 4.21%, and its shares lost 23.24% of their value over the last 52 weeks. On July 14, 2025, Becton, Dickinson and Company (NYSE:BDX) stock closed at $177.09 per share with a market capitalization of $50.755billion.

Oakmark Global Fund stated the following regarding Becton, Dickinson and Company (NYSE:BDX) in its second quarter 2025 investor letter:

"Becton, Dickinson and Company (NYSE:BDX) was the top de tractor during the quarter. The U.S.-headquartered health care equipment company’s stock price declined after it delivered weak fiscal second-quarter 2025 earnings. The earnings were negatively im pacted by several headwinds including research spending cuts, volume-based procurement challenges in China and pharma syringe destocking. In our view, the market is overlooking Becton Dickin son’s strong margin progress and operational improvements. We believe the company can lever age its prowess for innovation and low-cost manufacturing to unlock further value."

Becton, Dickinson and Company (NYSE:BDX) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 54 hedge fund portfolios held Becton, Dickinson and Company (NYSE:BDX) at the end of the first quarter, which was 56 in the previous quarter. While we acknowledge the potential of BDX) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

In another article, we covered Becton, Dickinson and Company (NYSE:BDX) and shared Heartland Mid Cap Value Fund’s views on the company in the previous quarter. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. This article is originally published at Insider Monkey.